Literature DB >> 9475540

Physiologic effects of extracellular superoxide dismutase transgene overexpression on myocardial function after ischemia and reperfusion injury.

E P Chen1, H B Bittner, R D Davis, P Van Trigt, R J Folz.   

Abstract

OBJECTIVE: Myocardial injury after ischemia and reperfusion may be mediated, in part, by oxygen-derived free radicals. In this study the protective effects of extracellular superoxide dismutase overexpression were directly assessed in the hearts of transgenic mice, after ischemia and reperfusion injury, using an isolated work-performing murine heart preparation and computerized analysis of functional data.
METHODS: A blinded study was performed to compare cardiac function in the hearts of both transgenic mice with a 3.5-fold overexpression of myocardial extracellular superoxide dismutase (n = 6, 22 to 26 gm) and littermate controls (n = 8, 22 to 26 gm). Preload-dependent cardiac output, contractility, heart rate, stroke work, and stroke volume were evaluated in the two groups before and after a 6-minute period of normothermic ischemia.
RESULTS: No differences were found between extracellular superoxide dismutase hearts and control hearts in any parameter of myocardial function before ischemia. After ischemia, decreases in cardiac output occurred in both groups; however, this decrease was larger in control mice compared with extracellular superoxide dismutase mice. A higher percentage of recovery was also observed in the contractility, heart rate, stroke work, and stroke volume of extracellular superoxide dismutase hearts compared with control hearts.
CONCLUSION: After global normothermic ischemia and subsequent reperfusion, decreases in cardiac function occurred in both extracellular superoxide dismutase and control mice; however, a higher percentage of recovery was observed in the extracellular superoxide dismutase overexpressed hearts. These data suggest that extracellular superoxide dismutase transgene overexpression significantly improves preservation of myocardial function after ischemia and reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475540     DOI: 10.1016/s0022-5223(98)70289-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Late phase ischemic preconditioning preserves mitochondrial oxygen metabolism and attenuates post-ischemic myocardial tissue hyperoxygenation.

Authors:  Yuanjing Li; Ming Cai; Yi Xu; Harold M Swartz; Guanglong He
Journal:  Life Sci       Date:  2010-11-02       Impact factor: 5.037

2.  Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.

Authors:  Jiahui Yu; Lingyan Wang; Mary Akinyi; Yuhong Li; Zhenzhen Duan; Yan Zhu; Guanwei Fan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine.

Authors:  Aindrila Chattopadhyay; Sabyasachi Biswas; Debashis Bandyopadhyay; Chinmoy Sarkar; Asoke G Datta
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 4.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 5.  Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases.

Authors:  Nguyen Hoai Nguyen; Gia-Buu Tran; Cuong Thach Nguyen
Journal:  J Mol Med (Berl)       Date:  2019-11-13       Impact factor: 4.599

6.  Mouse Models of Oxidative Stress Indicate a Role for Modulating Healthy Aging.

Authors:  Ryan T Hamilton; Michael E Walsh; Holly Van Remmen
Journal:  J Clin Exp Pathol       Date:  2012-06-20

Review 7.  Oxidative stress in congestive heart failure.

Authors:  P K Singal; N Khaper; F Farahmand; A Belló-Klein
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.